发明名称 |
Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
摘要 |
The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
|
申请公布号 |
US7105497(B2) |
申请公布日期 |
2006.09.12 |
申请号 |
US20050152866 |
申请日期 |
2005.06.14 |
申请人 |
|
发明人 |
|
分类号 |
A61K31/70;A61K31/52;A61K31/522;G01N33/00 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|